Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Uncategorized

Wells Fargo Maintains Overweight on AMETEK, Raises Price Target to $160

Wells Fargo analyst Allison Poliniak Cusic maintains AMETEK (NYSE:AME) with a Overweight and raises the price target from $140 to $160.

byBenzinga Newsdesk

April 20, 2021

1 minute read

Wells Fargo analyst Allison Poliniak Cusic maintains AMETEK (NYSE:AME) with a Overweight and raises the price target from $140 to $160.

Earnings

Ryan Specialty Group Earnings Preview

By Benzinga Insights

Today, 7:59 PM

Ryan Specialty Group (NYSE:RYAN) is set to give its latest quarterly earnings report on Tuesday, 2023-02-28. Here’s what…

RYAN

Piper Sandler Maintains Overweight on HubSpot, Raises Price Target to $830

By Benzinga Newsdesk

Today, 7:59 PM

Piper Sandler analyst Brent Bracelin maintains HubSpot (NYSE:HUBS) with a Overweight and raises the price target from $675 to $830.

HUBS

Keybanc Maintains Overweight on EOG Resources, Raises Price Target to $108

By Benzinga Newsdesk

Today, 7:59 PM

Keybanc analyst Leo Mariani maintains EOG Resources (NYSE:EOG) with a Overweight and raises the price target from $102 to $108.

EOG

Earnings

Asensus Surgical’s Return On Capital Employed Overview

By Benzinga Insights

Today, 7:59 PM

Benzinga Pro data, Asensus Surgical (AMEX:ASXC) reported Q2 sales of $994 thousand. Earnings fell to a loss of $19.62 million, resulting in a 2.57% decrease from last quarter.

ASXC

Wells Fargo Maintains Overweight on AMETEK, Raises Price Target to $160

Related Posts

Ryan Specialty Group Earnings Preview

Piper Sandler Maintains Overweight on HubSpot, Raises Price Target to $830

Keybanc Maintains Overweight on EOG Resources, Raises Price Target to $108

Asensus Surgical’s Return On Capital Employed Overview